Neumora Therapeutics, Correlations
| NMRA Stock | 1.56 0.01 0.65% |
The current 90-days correlation between Neumora Therapeutics, and Datadog is -0.01 (i.e., Good diversification). The correlation of Neumora Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Neumora Therapeutics, Correlation With Market
Significant diversification
The correlation between Neumora Therapeutics, Common and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neumora Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.
Neumora |
Moving together with Neumora Stock
| 0.72 | EXAS | EXACT Sciences | PairCorr |
| 0.71 | FATE | Fate Therapeutics | PairCorr |
| 0.76 | NVO | Novo Nordisk AS | PairCorr |
| 0.85 | INZY | Inozyme Pharma | PairCorr |
| 0.77 | KURA | Kura Oncology | PairCorr |
| 0.75 | NTLA | Intellia Therapeutics | PairCorr |
| 0.69 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.79 | ABOS | Acumen Pharmaceuticals | PairCorr |
| 0.83 | ADTX | Aditxt Inc | PairCorr |
| 0.72 | TCRX | Tscan Therapeutics | PairCorr |
| 0.87 | TERN | Terns Pharmaceuticals | PairCorr |
Moving against Neumora Stock
| 0.83 | GANX | Gain Therapeutics | PairCorr |
| 0.81 | CUE | Cue Biopharma | PairCorr |
| 0.73 | OPT | Opthea | PairCorr |
| 0.72 | LTRN | Lantern Pharma | PairCorr |
| 0.62 | TMO | Thermo Fisher Scientific | PairCorr |
| 0.59 | VERV | Verve Therapeutics | PairCorr |
| 0.56 | PFE | Pfizer Inc | PairCorr |
| 0.49 | WAT | Waters | PairCorr |
| 0.45 | FENC | Fennec Pharmaceuticals | PairCorr |
| 0.38 | A | Agilent Technologies | PairCorr |
| 0.75 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
| 0.73 | PHGE | Biomx Inc | PairCorr |
| 0.49 | CGTX | Cognition Therapeutics | PairCorr |
| 0.43 | CPRX | Catalyst Pharmaceuticals | PairCorr |
Related Correlations Analysis
| -0.81 | -0.65 | 0.0 | -0.32 | 0.77 | 0.18 | DDOG | ||
| -0.81 | 0.84 | 0.0 | 0.42 | -0.68 | -0.24 | K | ||
| -0.65 | 0.84 | 0.0 | 0.41 | -0.72 | -0.27 | ACI | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | DTATF | ||
| -0.32 | 0.42 | 0.41 | 0.0 | -0.58 | 0.03 | SFD | ||
| 0.77 | -0.68 | -0.72 | 0.0 | -0.58 | 0.06 | NOW | ||
| 0.18 | -0.24 | -0.27 | 0.0 | 0.03 | 0.06 | SPNS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Neumora Stock performing well and Neumora Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neumora Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DDOG | 1.89 | (0.28) | 0.00 | (0.50) | 0.00 | 3.24 | 15.86 | |||
| K | 0.14 | 0.04 | 0.37 | 1.33 | 0.00 | 0.35 | 0.79 | |||
| ACI | 1.05 | 0.17 | 0.12 | 0.43 | 1.24 | 2.39 | 7.71 | |||
| DTATF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SFD | 1.58 | 0.25 | 0.13 | (8.11) | 1.67 | 3.75 | 10.97 | |||
| NOW | 1.51 | (0.15) | 0.00 | (0.20) | 0.00 | 2.37 | 17.67 | |||
| SPNS | 1.13 | 0.02 | 0.02 | 0.00 | 1.45 | 2.61 | 7.48 |
Neumora Therapeutics, Corporate Management
| Jason JD | Chief Officer | Profile | |
| Nicholas Brandon | Chief Officer | Profile | |
| Amy Sullivan | Senior Resources | Profile | |
| John Reynders | Chief Advisor | Profile | |
| Maryjo ChamberlainTharp | Chief Officer | Profile | |
| Kaya Panandiker | Chief Officer | Profile |